Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (251-260 of 350) with videos related to

Pageof 35
Sort By:
Blood|January 1, 1990
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemiaR Mashal, M Shtalrid, M Talpaz, et al.
Blood|September 6, 2001
Phase 1 study of polyethylene glycol formulation of interferon alpha-2B (Schering 54031) in Philadelphia chromosome-positive chronic myelogenous leukemiaM Talpaz, S O'Brien, E Rose, et al.
Blood|September 1, 1988
Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reactionM S Lee, K S Chang, E J Freireich, et al.
Transfusion|May 1, 1983
Comparative functional analysis of lymphocytes and monocytes from plateletapheresisG Lopez-Berestein, J Reuben, E M Hersh, et al.
Experimental Hematology|June 1, 1992
Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemiaZ Estrov, E H Estey, M Andreeff, et al.
Blood|June 1, 1995
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cellsM Talpaz, H Kantarjian, J Liang, et al.
Blood|October 9, 1999
Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cellsZ Estrov, S K Manna, D Harris, et al.
Leukemia & Lymphoma|May 30, 2001
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phaseF J Giles, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancerM S Gordon, K Margolin, M Talpaz, et al.
Blood|May 15, 1995
Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemiaC F Verschraegen, M Talpaz, C F Hirsch-Ginsberg, et al.
Pageof 35

Showing results (251-260 of 350) with videos related to

Sort By:
Pageof 35
Blood|January 1, 1990
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemiaR Mashal, M Shtalrid, M Talpaz, et al.
Blood|September 6, 2001
Phase 1 study of polyethylene glycol formulation of interferon alpha-2B (Schering 54031) in Philadelphia chromosome-positive chronic myelogenous leukemiaM Talpaz, S O'Brien, E Rose, et al.
Blood|September 1, 1988
Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reactionM S Lee, K S Chang, E J Freireich, et al.
Transfusion|May 1, 1983
Comparative functional analysis of lymphocytes and monocytes from plateletapheresisG Lopez-Berestein, J Reuben, E M Hersh, et al.
Experimental Hematology|June 1, 1992
Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemiaZ Estrov, E H Estey, M Andreeff, et al.
Blood|June 1, 1995
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cellsM Talpaz, H Kantarjian, J Liang, et al.
Blood|October 9, 1999
Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cellsZ Estrov, S K Manna, D Harris, et al.
Leukemia & Lymphoma|May 30, 2001
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phaseF J Giles, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancerM S Gordon, K Margolin, M Talpaz, et al.
Blood|May 15, 1995
Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemiaC F Verschraegen, M Talpaz, C F Hirsch-Ginsberg, et al.
Pageof 35